| SP3 antibodies | | | This is a review about SP3 antibodies, based on 22 published articles using SP3 antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited SP3 antibody. |
| Santa Cruz Biotechnology search Santa Cruz Biotechnology SP3 products | | chip, emsa, ip, wb | Santa Cruz Biotechnology anti-Sp3 antibody was used in western blot, immunoprecipitation, EMSA, and ChIP assay to the collaboration of Pur alpha and Pur beta and its regulation of beta-myosin heavy chain gene expression during skeletal muscle inactivity. to the paper | | chip, emsa, wb | Santa Cruz Biotechnology anti-Sp3 antibody was used in human cells and in western blot, EMSA, ChIP assay to study the role for NF-Y and Sp1/Sp3 in the transcriptional regulation of the peptidylarginine deiminase type III gene (PADI3) in human keratinocytes. to the paper | | wb | Santa Cruz Biotechnology rabbit polyclonal anti-mouse Sp3 antibody was used in western blot to detect mouse Sp3 in WT and mutant MEF cell lines. to the paper | | wb | Santa Cruz Biotechnology Sp3 antibody was used in western blot to study the mechanisms involved in the transcriptional regulation of NHE2 and NHE3. to the paper | | emsa | Santa Cruz Biotechnology Sp3 (D-20; sc-644) antibody was used in EMSA assays to study the control of endothelial nitric-oxide synthase expression. to the paper | | emsa, ip | Santa Cruz Biotechnology anti-Sp3 antibody was used in human cells and in EMSA, immunoprecipitation to study the role for Sp1 in Akt-mediated induction of VEGF expression. to the paper | | emsa, wb | Santa Cruz Biotechnology antibody for Sp3 was used in western blot and EMSA to identify the methylation status of the core-promoter region of the chondromodulin-I gene as one of the mechanisms to determine the cell-specific expression of the ChM-I gene through the regulation of the binding of Sp3. to the paper | | chip | Santa Cruz Biotechnology anti-Sp3 antibody (sc-644X) was used in ChIP assay to study gene expression after DNA methyltransferase 1 knockdown in human lung carcinoma A549 and embryonal kidney HEK293 cells. to the paper | | emsa, ih, wb | Santa Cruz Biotechnology anti-Sp3 antibody H-225 or D-20 (sc-644X) was used in immunohistochemistry, western blot and EMSA to study the transcriptional regulation of the human chorionic gonadotropin ß gene during villous trophoblast differentiation. to the paper | | emsa | Santa Cruz Biotechnology polyclonal anti-Sp3 antibody was used in EMSA to study that induction of disease-associated keratin 16 gene expression by epidermal growth factor is regulated through cooperation of transcription factors Sp1 and c-Jun. to the paper | | emsa | Santa Cruz Biotechnology anti-Sp3 antibody was used in EMSA to study the DNA binding of Sp1 family members in nuclear extracts from C-28/I2 cells. to the paper | | emsa, wb | Santa Cruz polyclonal anti-Sp3 antibody was used in western blot and EMSA to study the effect of transforming growth factor- 1 (TGF- 1) on human type II collagen gene expression in articular chondrocytes and the relationship of it with Sp3/Sp1 ratio. to the paper | | emsa, wb | Santa Cruz Biotechnology anti-Sp3 antibody (sc-644) was used in western blot and EMSA to study expression of the human vacuolar H+-ATPase c subunit gene (ATP6L) in response to anticancer agents. to the paper | | emsa | Santa Cruz Biotechnology Sp3 antibody was used in EMSA to study transcriptional regulation of human luteinizing hormone receptor gene. to the paper | | emsa, wb | Santa Cruz Biotech Sp3 antibody was used in emsa and western blot to show that hPR regulates the promoter activity mediated through an active Sp1 site. to the paper | | block, ip, wb | Santa Cruz Biotechnology anti-Sp3 was used in immunoprecipitation to isolate Sp3 from A549 human lung cancer cells, in western blot to detect the intracellular level of Sp3 in human A549, and in blocking experiment to investigate the effect of antibody addition on the bingding of Sp3 to MMP-2 promoter in human A549 lung cancer cells. to the paper | | emsa | Santa Cruz Biotechnology polyclonal antisera against Sp3 was used in EMSA to investigate the binding of Sp3 to the -246/-225 MAO B Promoter Region in human HepG2 cells. to the paper | | emsa | Santa Cruz Biotechnology anti-Sp3 antibody was used in EMSA to characterize human beta-ENaC promoter. to the paper | | emsa | Santa Cruz anti-Sp3 antibody was used in EMSA to study the effect of histone deacetylase inhibitors on cyclooxygenase-1 in normal human astrocyte cells. to the paper | | ip | Santa Cruz Biotechnology rabbit anti-Sp3 (D-20) antibody was used in immunoprecipitation to study the interaction of DNA-binding proteins Puralpha, Purbeta, and MSY1 with transcriptional factors. to the paper |
| Millipore search Millipore SP3 products | | emsa, wb | Upstate Biotechnology rabbit polyclonal anti-Sp3 antibody was used in western blot and EMSA to study Sp3 and its DNA binding activity in nuclear extracts from either wild-type (WT) or Sp3 null (Sp3–/–) MEF cells. to the paper | | emsa | Upstate Biotechnology anti-Sp3 antibody was used in EMSA to study the induction of interleukin-21 receptor gene by T-cell receptor-induced Sp1 activity. to the paper | | wb | Upstate Biotechnology polyclonal anti-Sp3 antibody (catalogue no. 07–107) was used in human cells and in western blot to study the role for Sp1 in Akt-mediated induction of VEGF expression. to the paper |
| TEBU | | ic, wb | TEBU anti-Sp3 antibody was used in western blot and immunocytochemistry to study role of SP1 and SP3 transcription factors at promoter sites -690, -629, and -37 to regulation of human CETP gene expression. to the paper |
| Articles Reviewed | | 1: | Juan Ji et al. Puralpha and Purbeta collaborate with Sp3 to negatively regulate beta-myosin heavy chain gene expression during skeletal muscle inactivity. 2007 | | 2: | Sijun Dong et al. NF-Y and Sp1/Sp3 are involved in the transcriptional regulation of the peptidylarginine deiminase type III gene (PADI3) in human keratinocytes. 2006 | | 3: | Sonali Das et al. Activation of the RNA-dependent protein kinase PKR promoter in the absence of interferon is dependent upon Sp proteins. 2006 | | 4: | Jason E Fish et al. The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code. 2005 | | 5: | Zheng Wu et al. Interleukin-21 receptor gene induction in human T cells is mediated by T-cell receptor-induced Sp1 activity. 2005 | | 6: | Jaleh Malakooti et al. Zinc finger transcription factor Egr-1 is involved in stimulation of NHE2 gene expression by phorbol 12-myristate 13-acetate. 2005 | | 7: | Tomoki Aoyama et al. Methylation in the core-promoter region of the chondromodulin-I gene determines the cell-specific expression by regulating the binding of transcriptional activator Sp3. 2004 | | 8: | Snezana Milutinovic et al. DNA methyltransferase 1 knock down induces gene expression by a mechanism independent of DNA methylation and histone deacetylation. 2004 | | 9: | Martin Knöfler et al. Transcriptional regulation of the human chorionic gonadotropin beta gene during villous trophoblast differentiation. 2004 | | 10: | Nabendu Pore et al. Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism. 2004 | | 11: | Lujian Tan et al. Egr-1 mediates transcriptional repression of COL2A1 promoter activity by interleukin-1beta. 2003 | | 12: | Ying-Nai Wang et al. Induction of disease-associated keratin 16 gene expression by epidermal growth factor is regulated through cooperation of transcription factors Sp1 and c-Jun. 2003 | | 13: | Wilfried Le Goff et al. Regulation of human CETP gene expression: role of SP1 and SP3 transcription factors at promoter sites -690, -629, and -37. 2003 | | 14: | Christos Chadjichristos et al. Down-regulation of human type II collagen gene expression by transforming growth factor-beta 1 (TGF-beta 1) in articular chondrocytes involves SP3/SP1 ratio. 2002 | | 15: | Meiyi Tang et al. Progesterone receptor activates its promoter activity in human endometrial stromal cells. 2002 | | 16: | Leslie E Carlini et al. Cryptic MCAT enhancer regulation in fibroblasts and smooth muscle cells. Suppression of TEF-1 mediated activation by the single-stranded DNA-binding proteins, Pur alpha, Pur beta, and MSY1. 2002 | | 17: | Christie P Thomas et al. Genomic organization of the 5' end of human beta-ENaC and preliminary characterization of its promoter. 2002 | | 18: | Mei-Ren Pan et al. Nonsteroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 via suppression of the ERK/Sp1-mediated transcription. 2002 | | 19: | Takayuki Torigoe et al. Enhanced expression of the human vacuolar H+-ATPase c subunit gene (ATP6L) in response to anticancer agents. 2002 | | 20: | Ying Zhang et al. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex. 2002 | | 21: | Wai K Wong et al. Activation of human monoamine oxidase B gene expression by a protein kinase C MAPK signal transduction pathway involves c-Jun and Egr-1. 2002 | | 22: | Seijiro Taniura et al. Transcriptional regulation of cyclooxygenase-1 by histone deacetylase inhibitors in normal human astrocyte cells. 2002 |
|